Serina Therapeutics Inc. (SER) Income Statement Analysis - Revenue, Earnings & Profitability Metrics - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    Serina Therapeutics Inc.

    NYSE: SER · Real-Time Price · USD
    5.13
    -0.15 (-2.84%)
    At close: Sep 05, 2025, 12:37 PM

    Serina Therapeutics Income Statement

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
    Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
    Revenue
    		 56K 3.15M 500K 3.04M
    Cost of Revenue
    		 194K 90K 145K 150K
    Gross Profit
    		 -138K 3.06M 355K -110K
    Operating Income
    		 -17.05M -3.13M -2.27M -1.63M
    Interest Income
    		 n/a n/a 1.76K 10.86K
    Pretax Income
    		 -11.14M 5.27M -2.68M -1.26M
    Net Income
    		 -11.14M 5.27M -2.68M -1.26M
    Selling & General & Admin
    		 9.43M 3.89M 1.29M 6.71M
    Research & Development
    		 7.48M 2.39M 893K 1.32M
    Other Expenses
    		 194K -90K 4.68M -3.36M
    Operating Expenses
    		 17.1M 6.19M 6.86M 4.67M
    Interest Expense
    		 526K 558K 15.88K 3.09K
    Selling & Marketing Expenses
    		 n/a n/a n/a 5.41M
    Cost & Expenses
    		 17.1M 6.28M 2.77M 4.67M
    Income Tax Expense
    		 n/a -8K n/a n/a
    Shares Outstanding (Basic)
    		 7.36M 8.41M 1.08M 1.08M
    Shares Outstanding (Diluted)
    		 7.36M 8.41M 1.08M 1.08M
    EPS (Basic)
    		 -1.51 0.63 -2.49 -8.05
    EPS (Diluted)
    		 -1.51 0.63 -2.49 -8.05
    EBITDA
    		 -10.49M 5.92M -7.05M -7.35M
    EBIT
    		 -10.68M 5.83M -7.19M -7.49M
    Depreciation & Amortization
    		 194K 90K 132K 131K

    Add to Watchlist